Home Search
medicine management - search results
If you're not happy with the results, please do another search
STIMULATE Long Covid study: Opportunities for patients and innovation
The STIMULATE study will assess how patients with Long Covid progress and recover, explore innovative treatment options and investigates health inequalities
Lynn Rochester – Newcastle University
Lynn Rochester is Professor of Human Movement Science in the Translational and Clinical Research Institute, Newcastle University, UK, and an NIHR Senior Investigator
Her research interests are in ageing and neurodegenerative disease focused on the motor and non-motor mechanisms of gait and falls, surrogate markers of disease and disease progression,...
Beatrix Vereijken – Norwegian University of Science and Technology
Beatrix Vereijken is Professor of Medicine/Human Movement Science at the Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
She was an early recipient of the Royal Dutch Academy of Sciences fellowship, and co-founder and first Head of the Department of Human Movement Science...
The global cost of visual impairment
250 million people suffer from visual impairment at a global cost of $3 trillion, Translational Imaging Innovations explain.
Removing the blindfold on antimicrobial resistance
Here, several academic experts explain what we need to know about removing the blindfold on antimicrobial resistance - by strengthening clinical microbiology laboratories in resource-limited settings.
Eradicating dehydration in the elderly with Aquarate
Aquarate’s revolutionary fluid intake monitoring technology is helping to eradicate the problem of dehydration in the elderly community
Tuberculosis prevention efforts in Africa
Dr Michel Gasana & Dr Hugues Lago from WHO - Regional Office for Africa, spoke to OAG about the status of tuberculosis prevention
Non-melanoma skin cancer
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the main focus of non-melanoma skin cancer, including its steadily rising incidence in the UK.
New gene-silencing drug could help with ALS
New research suggests that in suppressing a mutated ALS gene, it may be possible to delay to onset of symptoms.
Investing in Switzerland’s researchers and their ideas
Assistant Editor of Open Access Government, investigates how the Swiss National Science Foundation (SNSF) is shaping research in Switzerland
The impact of cooking and cleaning on health
Professor of Indoor Air Chemistry examines exposure to indoor and outdoor pollution, through the impacts of cooking and cleaning on indoor air quality
Could replicating blood plasma accelerate wound healing?
New research indicates the potential to heal wounds may be assisted by replicating the plasma in blood through 3D printing to repair damaged tissues.
miRNAs in brain cancer therapy – Mighty things from small beginnings grow
Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy
Indigenous youth resilience: Water protectors
Dr Dawn Martin-Hill and Dr Christine Wekerle from McMaster University highlight Indigenous youth resilience research, including comment on what water teaches us.
Osteogenesis imperfecta – what we need to know
Frost & Sullivan’s TechCasting Group, places the spotlight on osteogenesis imperfecta – toward future targeted, more effective therapy.
The crisis of post-pandemic bed availability in the NHS
David Tyrrell, TeleTracking, explains why every minute matters when it comes to the bed availability crisis within the NHS.
On life support: The NHS desperately needs to modernise its data strategy
NHS Digital decision-makers desperately need to modernise their data strategy. Here we look at how this can be done.
The role of Institutional Investor in ESG investment chain in Japan
Professor Yumiko Miwa, Meiji University in Japan, discusses the role of the Institutional Investor in ESG investment chain in Japan.
Nemaura Medical: Helping patients stay in control of their health
We speak with Dr Faz Chowdhury, CEO of Nemaura Medical regarding the ground-breaking technology of non-invasive glucose sensors and more.
Optimising infection control post-pandemic
Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.